MJFF grant supports evaluation of Olatec’s dapansutrile in Parkinson’s disease progression models
March 13, 2023
Olatec Therapeutics LLC has been awarded a research grant by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to evaluate its lead molecule, dapansutrile (OLT-1177), in preclinical Parkinson’s disease progression models.